文献速递结核与非结核分枝杆菌

三基因Xpert宿主反应标志物用于儿童结核筛查的前瞻性诊断准确性研究

The Three-Gene Xpert Host Response Signature for Pediatric Tuberculosis Screening: A Prospective Diagnostic Accuracy Study.
PubMed 文献 · Clin Infect Dis · 2025-01-01

该研究在冈比亚和乌干达纳入181名15岁以下疑似肺结核儿童,评估GeneXpert MTB Host Response(Xpert-HR)筛查结核的准确性。HR TB评分截点-0.65在严格参考标准下灵敏度88.5%、特异度33.3%,特异度低有过度诊断风险,与CXR、Xpert Ultra或治疗决策算法联用未显著提升准确性。

要点

  • Xpert-HR对确诊结核灵敏度高(88.5%),但特异度低(33.3%),有过度诊断风险。
  • 与CXR、Xpert Ultra或治疗决策算法联用未显著提高准确性。
  • 5岁以下儿童灵敏度低于5-9岁和10-14岁儿童,特异度仍低。

核心结论

  • GeneXpert MTB Host Response对确诊结核显示高灵敏度但低特异度,存在过度诊断风险。
  • 需要改进儿童特异性基因标志物以提高准确性。

研究设计与样本

  • 前瞻性诊断准确性研究,纳入冈比亚和乌干达15岁以下接受肺结核评估的儿童181名。
  • 中位年龄4岁,53%女性,16%HIV阳性,14.4%确诊结核。
  • 每名儿童提供血样进行Xpert-HR检测,并接受标准结核评估包括胸部X线(CXR)和痰Xpert Ultra检测,随后按NIH病例分类为确诊、未确诊或不太可能结核。
  • 测量GBP5、DUSP3和TBP的循环阈值(Ct),计算HR TB评分并生成ROC曲线。
  • 在90%灵敏度下,按严格(SRS)、微生物学(MRS)和复合(CRS)参考标准评估特异度。

主要发现

  • HR TB评分截点-0.65在SRS下灵敏度88.5%、特异度33.3%,在MRS下特异度30.3%。
  • CRS下灵敏度75.7%,特异度33.3%。
  • 5-9岁和10-14岁儿童灵敏度高于5岁以下儿童,但特异度仍低(22.7%-28.6%)。
  • Xpert-HR与CXR、Xpert Ultra或结核治疗决策算法联用未显著提高准确性。

关键数值与推荐

  • HR TB评分截点-0.65:SRS灵敏度88.5%、特异度33.3%;MRS特异度30.3%;CRS灵敏度75.7%、特异度33.3%。
  • 5-9岁和10-14岁儿童特异度22.7%-28.6%。

临床怎么用

  • Xpert-HR高灵敏度可用于儿童结核筛查,但低特异度需警惕过度诊断。
  • 不宜单独依赖Xpert-HR进行儿童结核筛查决策。
  • 与CXR、Xpert Ultra或治疗决策算法联用未显著提升准确性,需综合评估。

局限性

  • 特异度低,存在过度诊断风险。
  • 5岁以下儿童灵敏度较低。
  • 与现有评估方法联用未显著提高准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Blood-based gene signatures offer potential as a near point-of-care tuberculosis (TB) screening tool. We examined the accuracy of the GeneXpert MTB Host Response (Xpert-HR) cartridge to screen for TB in children. METHODS: We enrolled children under 15 years from The Gambia and Uganda being evaluated for pulmonary TB. Each child provided a blood sample for Xpert-HR and underwent standard TB assessments, including chest X-ray (CXR) and sputum Xpert Ultra testing, followed by National Institutes of Health (NIH) case classification of Confirmed, Unconfirmed, or Unlikely TB. We measured cycle threshold (Ct) values for GBP5, DUSP3, and TBP, calculated an HR TB score, and generated ROC curves. Specificity was assessed at 90% sensitivity according to strict (SRS, Confirmed vs Unlikely TB), microbiological (MRS, Confirmed TB vs Unlikely or Unconfirmed TB), and composite (CRS, Confirmed or Unconfirmed TB vs Unlikely TB) reference standards compared with other TB evaluations. RESULTS: Among 181 children (median age 4 years; 53% female; 16% with HIV; 14.4% confirmed TB), the HR TB score cut-point of -0.65 showed 88.5% sensitivity with specificity at 33.3% (SRS) and 30.3% (MRS). Sensitivity was lower for the CRS at 75.7%, with similar specificity (33.3%). Sensitivity was higher in children aged 5-9 and 10-14 years compared with those under 5 years, but specificity remained low (22.7%-28.6%). Combining Xpert-HR with CXR, Xpert Ultra, or TB treatment decision algorithms did not significantly enhance accuracy. CONCLUSIONS: GeneXpert MTB Host Response showed high sensitivity for detecting confirmed TB but had low specificity, risking overdiagnosis. Improved pediatric-specific gene signatures are necessary for better accuracy in children.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Poore H, Wambi P, Nkereuwem E, et al. The Three-Gene Xpert Host Response Signature for Pediatric Tuberculosis Screening: A Prospective Diagnostic Accuracy Study. Clin Infect Dis. 2025. PMID: 40835229. doi:10.1093/cid/ciaf445

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。